Maternal Dyslipidemia, Plasma Branched-Chain Amino Acids, and the Risk of Child Autism Spectrum Disorder: Evidence of Sex Difference.

Doctors drew blood from 1,000 low-income moms early in pregnancy. They checked HDL cholesterol and branched-chain amino acids. They later tracked which kids got an autism diagnosis by age five.

The team also noted each baby's sex. They wanted to see if mom's blood levels plus boy or girl status changed autism odds.

Boys whose moms had low HDL and high BCAAs were twice as likely to develop autism. The same blood pattern did not raise risk for girls. Low HDL alone or high BCAAs alone mattered less than the pair together.

Aller et al. (2023) found high maternal testosterone also raised autism traits only in boys. Both papers point to a male-specific biological pathway that starts before birth.

Vargason et al. (2018) tried to use child plasma amino acids to spot autism. They failed; accuracy stayed under a large share. Mulder et al. (2020) shift the focus from kid blood to mom blood, showing prenatal levels can flag risk, not diagnose.

Whitehouse et al. (2014) linked prenatal vitamin use to lower autism odds. Their story is opposite but compatible: good nutrients protect, while bad lipid/amino balance harms. Together they argue for nutrition counseling in pregnancy.

When you meet a new preschool client, ask mom about her prenatal lipid or metabolic labs if they exist. Low HDL plus high BCAAs in a boy's history can guide you to watch social communication milestones extra closely. You can also use the info to encourage moms of future siblings to request early metabolic screening with their OB-GYN. The study does not give a cut-off score, but it arms you with concrete talking points about why nutrition and sex-specific risk matter in autism assessment.